BMO Starts ArQule (ARQL), Pharmasset (VRUS) at Outperform

September 29, 2010 5:28 PM EDT
Get Alerts ARQL Hot Sheet
Price: $2.32 --0%

Rating Summary:
    3 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 35 | Down: 24 | New: 12
Trade ARQL Now!
Join SI Premium – FREE
An analyst at BMO Capital has initiated coverage on several stocks in the Biotech & Drugs sector this afternoon, both with Outperform ratings: ArQule (Nasdaq: ARQL) and Pharmasset (Nasdaq: VRUS).

The firm set a $10 price target on ArQule shares and a $41 price target on shares of Pharmasset.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

BMO Capital

Add Your Comment